Lifecome BiochemistryLtd Balance Sheet Health
Financial Health criteria checks 0/6
Lifecome BiochemistryLtd has a total shareholder equity of CN¥258.8M and total debt of CN¥865.9M, which brings its debt-to-equity ratio to 334.5%. Its total assets and total liabilities are CN¥1.7B and CN¥1.4B respectively.
Key information
334.5%
Debt to equity ratio
CN¥865.89m
Debt
| Interest coverage ratio | n/a |
| Cash | CN¥14.52m |
| Equity | CN¥258.84m |
| Total liabilities | CN¥1.44b |
| Total assets | CN¥1.70b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 002868's short term assets (CN¥237.4M) do not cover its short term liabilities (CN¥722.7M).
Long Term Liabilities: 002868's short term assets (CN¥237.4M) do not cover its long term liabilities (CN¥719.0M).
Debt to Equity History and Analysis
Debt Level: 002868's net debt to equity ratio (328.9%) is considered high.
Reducing Debt: 002868's debt to equity ratio has increased from 11.4% to 334.5% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 002868 has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: 002868 has less than a year of cash runway if free cash flow continues to reduce at historical rates of 39% each year